harmaline has been researched along with oxidopamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, ES; Jang, YY; Kim, DH; Lee, CS | 1 |
| Kolasiewicz, W; Kuter, K; Nowak, P; Ossowska, K; Pastuszka, A | 1 |
| Berghauzen, K; Kolasiewicz, W; Kuter, K; Nowak, P; Ossowska, K; Schulze, G | 1 |
3 other study(ies) available for harmaline and oxidopamine
| Article | Year |
|---|---|
Protective effect of harmaline and harmalol against dopamine- and 6-hydroxydopamine-induced oxidative damage of brain mitochondria and synaptosomes, and viability loss of PC12 cells.
Topics: Animals; Brain; Calcium; Cell Survival; Deoxyribose; Dopamine; Harmaline; Intracellular Membranes; Mitochondria; Neurons; Neuroprotective Agents; Oxidation-Reduction; Oxidative Stress; Oxidopamine; PC12 Cells; Permeability; Proteins; Rats; Sulfhydryl Compounds; Synaptosomes; Thioredoxin-Disulfide Reductase | 2001 |
Lesion of the cerebellar noradrenergic innervation enhances the harmaline-induced tremor in rats.
Topics: Adrenergic Agents; Animals; Brain Chemistry; Central Nervous System Stimulants; Cerebellum; Chromatography, High Pressure Liquid; Dopamine; Harmaline; Male; Neural Pathways; Norepinephrine; Oxidopamine; Rats; Rats, Wistar; Serotonin; Synaptic Transmission; Tremor | 2011 |
6-OHDA injections into A8-A9 dopaminergic neurons modelling early stages of Parkinson's disease increase the harmaline-induced tremor in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Agents; Animals; Central Nervous System Stimulants; Cerebellum; Chromatography, High Pressure Liquid; Dopaminergic Neurons; Harmaline; Hydroxyindoleacetic Acid; Male; Motor Activity; Oxidopamine; Parkinson Disease; Rats; Rats, Wistar; Serotonin; Statistics, Nonparametric; Substantia Nigra; Tremor; Tyrosine 3-Monooxygenase | 2012 |